Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS

Anatomical Record

Volumn 292, Issue 3, 2009, Pages 455-460

  Li, Yong Zhe ^a   Hu, Chao Jun ^a   Leng, Xiao Mei ^a   Zhao, Guan Fei ^a   Li, Ning ^b   Xu, Yang ^b,c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Biomarker; Magnetic beads; MALDI TOF MS; Primary biliary cirrhosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MAGNETICS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 65549169250     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20870     Document Type: Article

References (27)

1. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S. 2006. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368:1012-1021.
2. Baumeister W. 2005. From proteomic inventory to architecture. FEBS Lett 579:933-937.
3. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW. 2002. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 293:1566-1570.
4. Chung CH, Levy S, Chaurand P, Carbone DP. 2007. Genomics and proteomics: emerging technologies in clinical cancer research. Crit Rev Oncol Hematol 61:1-25.
5. De Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP. 2005. Discovery of new rheumatoid arthritis biomarkers using the surface- enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 52:3801-3812.
6. Dotzlaw H, Schulz M, Eggert M, Neeck G. 2004. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta 1696:121-129.
7. Hayman MW, Przyborski SA. 2004. Proteomic identification of biomarkers expressed by human pluripotent stem cells. Biochem Biophys Res Commun 316:918-923.
8. He XS, Ansari AA, Ridgway WM, Coppel RL, Gershwin ME. 2006. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 239:1-13.
9. Heathcote EJ. 2000. Management of primary biliary cirrhosis, management of primary biliary cirrhosis. The American Association for the study of liver diseases practice guidelines. Hepatology 31:1005-1013.
10. Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, Wang Y, Chen M, Wu D, Wang Y, Bi S, Qiu Y, Lu P, Cheng J, Xiao B, Hu L, Gao X, Liu J, Wang Y, Song Y, Zhang L, Suo F, Chen T, Huang Z, Zhao Y, Lu H, Pan C, Tang H. 2005. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 51:56-64.
11. Kaplan MM. 1996. Primary biliary cirrhosis. N Engl J Med 335:1570-1580.
12. Kaplan MM, Gershwin ME. 2005. Primary biliary cirrhosis. N Engl J Med 353:1261-1273.
13. Kim WR, Ludwig J, Lindor KD. 2000. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 95:1130-1138.
14. Leung PS, Coppel RL, Ansari A, Munoz S, Gershwin ME. 1997. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 17:61-69.
15. Locke GR, III, Therneau TM, Ludwig J, Dickson ER, Lindor KD. 1996. Time course of histological progression in primary biliary cirrhosis. Hepatology 23:52-56.
16. Metcalf J, James O. 1997. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 17:13-22.
17. Miyakawa H, Tanaka A, Selmi C, Hosoya N, Mataki N, Kikuchi K, Kato T, Arai J, Goto T, Gershwin ME. 2006. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis. Clin Dev Immunol 13:289-294.
18. Neuberger J. 1997. Primary biliary cirrhosis. Lancet 350:875-879.
19. Sakauchi F, Mori M, Zeniya M, Toda G. 2006. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 16:30-34.
20. Shiwa M, Nishimura Y, Wakatabe R, Fukawa A, Arikuni H, Ota H, Kato Y, Yamori T. 2003. Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem Biophys Res Commun 309:18-25.
21. Sinz A, Kalkhof S, Ihling C. 2005. Mapping protein interfaces by a trifunctional cross-linker combined with MALDI-TOF and ESIFTICR mass spectrometry. J Am Soc Mass Spectrom 16:1921-1931.
22. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, Tsuji T, Omata M. 1997. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 26:1207-1212.
23. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P. 2004. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76:1560-1570.
24. Whiteaker JR, Zhao L, Zhang HY, Feng LC, Piening BD, Anderson L, Paulovich AG. 2007. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 362:44-54.
25. Wiesner A. 2004. Detection of tumor markers with ProteinChip technology. Curr Pharm Biotechnol 5:45-67.
26. Wong GL, Hui AY, Wong VW, Chan FK, Sung JJ, Chan HL. 2005. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am J Gastroenterol 100:2205-2211.
27. Zeniya M, Watanabe F, Morizane T, Shibata M, Maeyama S, Kage M, Nakanuma Y, Toda G. 2005. Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model. J Gastroenterol 40:1148-1154.